Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 4, 2023
[New concepts in multiple myeloma by returning to cytogenetics]Taku Tsukamoto
Expert Opinion on Therapeutic Targets|July 23, 2026
The PDPK1-RSK2 axis as a potential convergent therapeutic vulnerability in B-cell lymphomasJunya Kuroda, Taku Tsukamoto, Yuji Shimura
Journal of Medical Microbiology|May 5, 2017
Assessment of urinary pharmacokinetics and pharmacodynamics of orbifloxacin in healthy dogs with ex vivo modellingTakae Shimizu, Kazuki Harada, Saki Manabe, et al.
Leukemia & Lymphoma|March 25, 2025
Phosphorylation status and prognostic impacts of RSK2, PDPK1, and AKT in malignant lymphomaAkio Onishi, Aya Miyagawa-Hayashino, Haruya Okamoto, et al.
Cureus|June 5, 2024
Good's Syndrome With Pure Red Cell Aplasia and Subclinical Myasthenia Gravis: A Case Report and Review of LiteratureWakana Hashiro, Akihiro Miyashita, Yuka Kawaji-Kanayama, et al.
Chemical & Pharmaceutical Bulletin|March 18, 2026
Synthesis and Evaluation of a Potential RSK2 Degrader in Human Multiple Myeloma Cell LinesDaisuke Ide, Hidetomo Yokoo, Shinsuke Mizutani, et al.
Cureus|September 2, 2025
Late-Onset Angioimmunoblastic T-cell Lymphoma During Nivolumab Treatment for MelanomaAkihiro Miyashita, Taichi Murao, Yuji Shimura, et al.
Internal Medicine (Tokyo, Japan)|August 16, 2023
Management of Acquired Factor X Deficiency Caused by In Vitro Non-neutralizing Anti-factor X Autoantibodies with Pre-emptive Corticosteroid TherapyAkio Onishi, Yuji Shimura, Takahisa Nakamura, et al.
Pageof 8